The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. [electronic resource]
Producer: 20180926Description: 330-332 p. digitalISSN:- 1543-0790
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- BRCA1 Protein -- antagonists & inhibitors
- BRCA2 Protein -- antagonists & inhibitors
- Breast Neoplasms -- drug therapy
- Capecitabine -- therapeutic use
- Female
- Furans -- therapeutic use
- Gene Expression Regulation, Neoplastic
- Humans
- Indazoles -- therapeutic use
- Indoles -- therapeutic use
- Ketones -- therapeutic use
- Mutation
- Phthalazines -- therapeutic use
- Piperazines -- therapeutic use
- Piperidines -- therapeutic use
- Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
- Poly(ADP-ribose) Polymerases -- genetics
- Prognosis
- Randomized Controlled Trials as Topic
- Survival Analysis
- Vinblastine -- analogs & derivatives
- Vinorelbine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.